What is Orreco?
Orreco operates at the vanguard of the sports technology sector, specializing in the synthesis of complex physiological data and biostatistical modeling. By deploying sophisticated cognitive computing platforms, the firm provides coaches, medical practitioners, and elite athletes with precise, evidence-based insights. This capability allows organizations to mitigate injury risks and sustain peak performance levels, effectively bridging the gap between raw biological data and high-stakes decision-making in professional sports.
The firm's market position is defined by its deep integration into the daily workflows of elite teams, where its proprietary algorithms serve as a cornerstone for performance management. As the industry shifts toward more rigorous, data-centric methodologies, Orreco remains a primary partner for organizations seeking to gain a competitive edge through scientific rigor and technological innovation.
How much funding has Orreco raised?
Orreco has raised a total of $10.7M across 4 funding rounds:
Unspecified
$1.1M
Series A
$2M
Unspecified
$3.6M
Unspecified
$4M
Unspecified (2015): $1.1M, investors not publicly disclosed
Series A (2017): $2M led by True Ventures
Unspecified (2021): $3.6M supported by True Ventures, Graeme McDowell, and Padraig Harrington
Unspecified (2025): $4M featuring The Twenty Minute Vc and True Ventures
Key Investors in Orreco
True Ventures
True Ventures is a founder-first venture capital firm that partners with creative teams at the earliest stages, providing capital, guidance, and a strong community to help build enduring technology and artificial intelligence-driven companies.
The Twenty Minute Vc
20VC operates at the intersection of venture capital and media, providing insights through podcasts and newsletters while focusing on delivering content related to venture capital trends, market analysis, and investment strategies.
Graeme McDowell
A professional athlete and strategic investor who brings domain-specific expertise and industry connections to the Orreco growth narrative.
What's next for Orreco?
With the successful closure of this major strategic investment, Orreco is well-positioned to accelerate its product development roadmap and expand its footprint within the global sports enterprise market. The capital will likely be deployed to enhance the scalability of its cognitive computing architecture and to deepen its research capabilities in predictive physiology. As the company scales, it is expected to further integrate its solutions into broader health and wellness ecosystems, potentially diversifying its client base beyond professional sports into high-performance corporate and medical sectors.
The strategic backing from established venture partners suggests a long-term commitment to building a durable, technology-first organization. Moving forward, Orreco will likely focus on deepening its data moats and establishing new benchmarks for performance analytics, ensuring that its platform remains the gold standard for organizations that view athlete health as a critical business asset.
